In Russian could be removed from production nearly 300 vital medicines, reports Kommersant with reference to the Federal Anti-Monopoly Service (FAS).
197 medical drugs from the government’s vital and essential medical list with fixed price not over 50 rubles (less than 1 euro) have been already removed from production, while about 160 are awaiting the same fate.
Under Russian law, the prices of medicines from the vital and essential list are set by the government, and FAS urged the Cabinet in its letter to increase the prices of the cheapest medicines by 5 rubles, Kommersant reported.
According to DSM Group, in 2015, there were 10 thousand items of medicines from the vital and essential list available in Russia. In monetary terms, they accounted for 15.4 billion rubles., 6.3% of the total commercial retail market.
The main reason in the FAS letter was named low profitability manufacturing medicines from the vital and essential list due to increased costs of raw materials.
A previous attempt by FAS and the ministries of health, industry and trade, economics, and finance to get the prices on medicines from the essential list increased by 30 percent was rejected a year ago, Kommersant reported.
At the same time, according to the Minister of Health Veronika Skvortsova, in February 2016, there was a decrease also in import of these medicines, as it became unprofitable to import cheap drugs due to devaluation of the ruble. The number has already decreased by some 8-9%.
Print this entry